PR Newswire (Canada) — All Releases·TW·Mon, 24 Aug 2026 00:00:00 UTC

Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

TAIPEI, Aug. 23, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduate...

Open original ↗Open in cockpit

Read releases like this the second they cross the wire.

1,400+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 72-hour free trial, no card required.

Start the free trial →

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.

PPN Source →

Shared via PPN World — real-time press release intelligence.